Hematology TimesCAR T-cell therapy gets breakthrough designationNovember 26, 2014Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesPonatinib approved in AustraliaNovember 26, 2014Leukemia, Myelodysplasia, TransplantationPharmacy
Hematology TimesFDA grants drug orphan designation for AMLNovember 21, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA grants CAR T-cell therapy orphan designationNovember 19, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesProduct approved for hemophilia A in Canada, AustraliaNovember 13, 2014ThrombosisPharmacy
Hematology TimesHematology drugs on the fast trackNovember 9, 2014CythemiasLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesNICE recommends ofatumumab in CLLNovember 6, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesFDA lifts clinical hold on imetelstatNovember 5, 2014CythemiasMultiple MyelomaPharmacy
Hematology TimesEMA grants product orphan status for AMLNovember 1, 2014Leukemia, Myelodysplasia, TransplantationPharmacy
Hematology TimesDrug gets orphan status for PNH in USOctober 29, 2014AnemiaThrombosisPharmacyBleeding Disorders
Hematology TimesCHMP says ponatinib’s benefits outweigh risksOctober 26, 2014Leukemia, Myelodysplasia, TransplantationPharmacy
